China Detains AstraZeneca Staff in Data, Drug-Import Probes
- People being questioned are from drugmaker’s oncology division
- Police in Shenzhen leading investigation, people familiar say
This article is for subscribers only.
Police in China have detained five current and former employees of British drugmaker AstraZeneca Plc for questioning about potential illegal activities, according to people familiar with the matter.
The individuals being held are all Chinese citizens who marketed cancer drugs in AstraZeneca’s oncology division, the people said, asking not to be identified discussing private information. The investigation is being led by police in the southern metropolis of Shenzhen, and the detentions took place earlier in the summer, the people said.